- Exchange: Stockholm
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Oasmia Pharmaceutical AB+ Add to Watchlist
OASM:SS20.1000 SEK 0.2000 1.01%
As of 06:59:59 ET on 04/17/2014.
Company Profile for Oasmia Pharmaceutical AB (OASM)
Oasmia Pharmaceutical AB is a pharmaceutical company that specializes in human and veterinary oncology. The Company's develops the semi-synthesized substances for different therapeutic areas, primarily for anti-cancer chemotherapy. Oasmia also conducts research within antibiotics, asthma and neurologically targeted drugs in clinical or preclinical stages.
Oasmia Pharmaceutical AB
Key Executives for Oasmia Pharmaceutical AB (OASM)
|Joel Tomas CitronChairman||Julian AleksovCEO/Co-Founder|
|Hans SundinExecutive Vice President||Margareta ErikssonVP:Clinical Development|
|Ingela HagglundVP:Operations||Annette LjungmarkHead:Accounting & Human Resources|
|Mikael AspHead:Quality Assurance|